Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Estera Rintz"'
Autor:
Estera Rintz, Betul Celik, Nidhi Fnu, Angélica María Herreño-Pachón, Shaukat Khan, Eliana Benincore-Flórez, Shunji Tomatsu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 2, Pp 102211- (2024)
Mucopolysaccharidosis type IVA (MPS IVA) is caused by a deficiency of the galactosamine (N-acetyl)-6-sulfatase (GALNS) enzyme responsible for the degradation of specific glycosaminoglycans (GAGs). The progressive accumulation of GAGs leads to various
Externí odkaz:
https://doaj.org/article/2f3e9aa130624ddab430b233b94c89ae
Autor:
Dominika Bębnowska, Rafał Hrynkiewicz, Karolina Wiśniewska, Magdalena Żabińska, Estera Rintz, Karolina Pierzynowska, Paulina Niedźwiedzka-Rystwej
Publikováno v:
Frontiers in Microbiology, Vol 14 (2024)
Rabbit Haemorrhagic Disease (RHD) is a severe disease caused by Lagovirus europaeus/GI.1 and GI.2. Immunological processes such as apoptosis are important factors involved in the pathogenesis of Rabbit Haemorrhagic Disease (RHD). The process of progr
Externí odkaz:
https://doaj.org/article/0bcf610259124131855795b400d25fcd
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 1113 (2024)
Mucopolysaccharidoses (MPSs) are a group of inborn errors of the metabolism caused by a deficiency in the lysosomal enzymes required to break down molecules called glycosaminoglycans (GAGs). These GAGs accumulate over time in various tissues and disr
Externí odkaz:
https://doaj.org/article/7ceef241404e448d9c7a1b9eed227b01
Autor:
Estera Rintz, Takashi Higuchi, Hiroshi Kobayashi, Deni S. Galileo, Grzegorz Wegrzyn, Shunji Tomatsu
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 24, Iss , Pp 71-87 (2022)
More than 50 lysosomal storage diseases (LSDs) are associated with lysosomal dysfunctions with the frequency of 1:5,000 live births. As a result of missing enzyme activity, the lysosome dysfunction accumulates undegraded or partially degraded molecul
Externí odkaz:
https://doaj.org/article/c83e54ba5bdb496cb03c6ad380a4ec53
Autor:
Katarzyna Kosznik-Kwaśnicka, Magdalena Podlacha, Łukasz Grabowski, Małgorzata Stasiłojć, Alicja Nowak-Zaleska, Karolina Ciemińska, Zuzanna Cyske, Aleksandra Dydecka, Lidia Gaffke, Jagoda Mantej, Dorota Myślińska, Agnieszka Necel, Karolina Pierzynowska, Ewa Piotrowska, Edyta Radzanowska-Alenowicz, Estera Rintz, Krzysztof Sitko, Gracja Topka-Bielecka, Grzegorz Węgrzyn, Alicja Węgrzyn
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Phage therapy is a promising alternative treatment of bacterial infections in human and animals. Nevertheless, despite the appearance of many bacterial strains resistant to antibiotics, these drugs still remain important therapeutics used in human an
Externí odkaz:
https://doaj.org/article/610636f6eaa940bdaafc1decc571dca4
Publikováno v:
Cells, Vol 12, Iss 13, p 1782 (2023)
The main approach used in the current therapy of mucopolysaccharidosis (MPS) is to reduce the levels of glycosaminoglycans (GAGs) in cells, the deposits considered to be the main cause of the disease. Previous studies have revealed significant differ
Externí odkaz:
https://doaj.org/article/daa6cf8e34834ebb8605a5e9a6e1f458
Autor:
Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Fnu Nidhi, Shaukat Khan, Eliana Benincore-Flórez, Shunji Tomatsu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 9890 (2023)
Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is caused by a deficiency of the N-acetylgalactosamine-6-sulfate-sulfatase (GALNS) enzyme, leading to the accumulation of glycosaminoglycans (GAG), keratan sulfate (KS) and chondroitin-6-sulfate
Externí odkaz:
https://doaj.org/article/5f935db31f514f9f8ccaa947f2cb47e5
Autor:
Karolina Pierzynowska, Lidia Gaffke, Magdalena Żabińska, Zuzanna Cyske, Estera Rintz, Karolina Wiśniewska, Magdalena Podlacha, Grzegorz Węgrzyn
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 3887 (2023)
The oxytocin receptor (OXTR), encoded by the OXTR gene, is responsible for the signal transduction after binding its ligand, oxytocin. Although this signaling is primarily involved in controlling maternal behavior, it was demonstrated that OXTR also
Externí odkaz:
https://doaj.org/article/016ad8ee06bd4c0ab431b845b7bddb3e
Autor:
Magdalena Żabińska, Lidia Gaffke, Patrycja Bielańska, Magdalena Podlacha, Estera Rintz, Zuzanna Cyske, Grzegorz Węgrzyn, Karolina Pierzynowska
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 704 (2023)
Mucopolysaccharidoses (MPS) are rare genetic disorders belonging to the lysosomal storage diseases. They are caused by mutations in genes encoding lysosomal enzymes responsible for degrading glycosaminoglycans (GAGs). As a result, GAGs accumulate in
Externí odkaz:
https://doaj.org/article/72b76420239a4d05b4ecaac03a97de37
Autor:
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 477 (2022)
Mucopolysaccharidoses (MPSs) constitute a heterogeneous group of lysosomal storage disorders characterized by the lysosomal accumulation of glycosaminoglycans (GAGs). Although lysosomal dysfunction is mainly affected, several cellular organelles such
Externí odkaz:
https://doaj.org/article/9e76a49bcb9b4ab6ae0434ec0473e216